{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T22:26:30Z","timestamp":1769898390592,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Radius Health Inc","award":["NCT01657162"],"award-info":[{"award-number":["NCT01657162"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00198-020-05555-1","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T19:02:33Z","timestamp":1600196553000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-9801","authenticated-orcid":false,"given":"N.B.","family":"Watts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-4423","authenticated-orcid":false,"given":"R.K.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6721-1318","authenticated-orcid":false,"given":"S.","family":"Baim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7050-0703","authenticated-orcid":false,"given":"B.","family":"Mitlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-7703","authenticated-orcid":false,"given":"G.","family":"Hattersley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-9836","authenticated-orcid":false,"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5003-0924","authenticated-orcid":false,"given":"T.D.","family":"Rozental","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5797-4947","authenticated-orcid":false,"given":"M.S.","family":"LeBoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"5555_CR1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/00001648-199611000-00008","volume":"7","author":"JA Baron","year":"1996","unstructured":"Baron JA, Karagas M, Barrett J, Kniffin W, Malenka D, Mayor M, Keller RB (1996) Basic epidemiology of fractures of the upper and lower limb among Americans over 65 years of age. Epidemiology 7:612\u2013618","journal-title":"Epidemiology"},{"key":"5555_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ocl.2018.10.004","volume":"50","author":"JC Wu","year":"2019","unstructured":"Wu JC, Strickland CD, Chambers JS (2019) Wrist fractures and osteoporosis. Ortho Clin North Am 50:211\u2013221","journal-title":"Ortho Clin North Am"},{"key":"5555_CR3","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/jbmr.2559","volume":"30","author":"CJ Crandall","year":"2015","unstructured":"Crandall CJ, Hovey KM, Cauley JA, Andrews CA, Curtis JR, Wactawski-Wende J, Wright NC, Li W, LeBoff MS (2015) Wrist fracture and risk of subsequent fracture: findings from the Women\u2019s Health Initiative study. J Bone Miner Res 30:2086\u20132095","journal-title":"J Bone Miner Res"},{"key":"5555_CR4","doi-asserted-by":"publisher","first-page":"c3324","DOI":"10.1136\/bmj.c3324","volume":"341","author":"BJ Edwards","year":"2010","unstructured":"Edwards BJ, Song J, Dunlop DD, Fink HA, Cauley JA (2010) Functional decline after incident wrist fractures--study of osteoporotic fractures: prospective cohort study. BMJ 341:c3324","journal-title":"BMJ"},{"key":"5555_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF02546396","volume":"20","author":"RA Schlenker","year":"1976","unstructured":"Schlenker RA, VonSeggen WW (1976) The distribution of cortical and trabecular bone mass along the lengths of the radius and ulna and the implications for in vivo bone mass measurements. Calcif Tissue Res 20:41\u201352","journal-title":"Calcif Tissue Res"},{"key":"5555_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/jbmr.3299","volume":"33","author":"E Biver","year":"2018","unstructured":"Biver E, Durosier-Izart C, Chevalley T, van Rietbergen B, Rizzoli R, Ferrari S (2018) Evaluation of radius microstructure and areal bone mineral density improves fracture prediction in postmenopausal women. J Bone Miner Res 33:328\u2013337","journal-title":"J Bone Miner Res"},{"key":"5555_CR7","unstructured":"ISCD Official positions 2015. Adult and Pediatric (Accessed May 31, 2019)"},{"key":"5555_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1148\/radiology.219.1.r01ap1311","volume":"219","author":"CA Goldfarb","year":"2001","unstructured":"Goldfarb CA, Yin Y, Gilula LA, Fisher AJ, Boyer MI (2001) Wrist fractures: what the clinician wants to know. Radiology 219:11\u201328","journal-title":"Radiology"},{"key":"5555_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00198-017-4323-6","volume":"29","author":"N Doyle","year":"2018","unstructured":"Doyle N, Varela A, Haile S, Guldberg R, Kostenuik PJ, Ominsky MS, Smith SY, Hattersley G (2018) Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption. Osteoporos Int 29:685\u2013697","journal-title":"Osteoporos Int"},{"key":"5555_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/en.2015-1726","volume":"157","author":"G Hattersley","year":"2016","unstructured":"Hattersley G, Dean T, Corbin BA, Bahar H, Gardella TJ (2016) Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling. Endocrinology 157:141\u2013149","journal-title":"Endocrinology"},{"key":"5555_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00223-016-0171-1","volume":"99","author":"H Bahar","year":"2016","unstructured":"Bahar H, Gallacher K, Downall J, Nelson CA, Shomali M, Hattersley G (2016) Six weeks of daily Abaloparatide treatment increased vertebral and femoral bone mineral density, microarchitecture and strength in ovariectomized osteopenic rats. Calcif Tissue Int 99:489\u2013499","journal-title":"Calcif Tissue Int"},{"key":"5555_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2016.11136","volume":"316","author":"PD Miller","year":"2016","unstructured":"Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, Alexandersen P, Zerbini CAF, Hu MY, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C, for the ACTIVE Study Investigators (2016) Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 316:722\u2013733","journal-title":"JAMA"},{"key":"5555_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00198-019-04890-2","volume":"30","author":"NB Watts","year":"2019","unstructured":"Watts NB, Hattersley G, Fitzpatrick LA, Wang Y, Williams GC, Miller PD, Cosman F (2019) Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 30:1187\u20131194","journal-title":"Osteoporos Int"},{"key":"5555_CR14","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1210\/jc.2018-00163","volume":"103","author":"HG Bone","year":"2018","unstructured":"Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Russo LA, Alexandersen P, Zerbini CA, Hu MY, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C, ACTIVE Study Investigators (2018) ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis. J Clin Endocrinol Metab 103:2949\u20132457","journal-title":"J Clin Endocrinol Metab"},{"key":"5555_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1385\/JCD:4:2:105","volume":"4","author":"SL Bonnick","year":"2001","unstructured":"Bonnick SL, Johnston CC Jr, Kleerekoper M, Lindsay R, Miller P, Sherwood L, Siris E (2001) Importance of precision in bone density measurements. J Clin Densitom 4:105\u2013110","journal-title":"J Clin Densitom"},{"key":"5555_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/jc.2014-3718","volume":"100","author":"BZ Leder","year":"2015","unstructured":"Leder BZ, O'Dea LS, Zanchetta JR, Kumar P, Banks K, Banks K, McKay K, Lyttle CR, Hattersley G (2015) Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 100:697\u2013706","journal-title":"J Clin Endocrinol Metab"},{"key":"5555_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/jbmr.3641","volume":"34","author":"ML Bouxsein","year":"2019","unstructured":"Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM (2019) Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res 34:632\u2013642","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05555-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05555-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05555-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T02:29:03Z","timestamp":1631672943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05555-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5555"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05555-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"NB Watts is a speaker for Amgen and Radius\u00a0Health, Inc., and a consultant for AbbVie, Amgen, and Sanofi. RK Dore is a speaker for Radius Health, Inc., and is a speaker, consultant, and has been involved in clinical trials for Amgen and Eli Lilly and Company. MS LeBoff receives grant\/research support from the National Institute of Health\/National Institute of Arthritis and Musculoskeletal and Skin Diseases and owns a company stock in Amgen. B Mitlak and Y Wang are employees of and own company stock in Radius Health, Inc. G Hattersley is a former employee of and consultant to Radius Health, Inc. S Baim declares that he has no conflicts of interest to disclose and TD Rozental is the Editor in Chief of the <i>Journal of Hand Surgery Global Online.<\/i>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest disclosure"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethics committee at all participating institutions and were conducted according to the recommendations of Good Clinical Practice and all other applicable local regulatory and ethical requirements and the Declaration of Helsinki (revised edition, Tokyo 2004).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}